Kyorin Pharmaceutical Q1 FY27 profit attributable to owners drops 60.8% to JPY 824 million

Reuters2026/07/30 07:50

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Kyorin Pharmaceutical posted Q1 net sales of JPY 29.65 billion, down 1.9% year-on-year.
Operating profit plunged 59.3% to JPY 964 million, while profit attributable to owners of parent slid 60.8% to JPY 824 million.
Full-year guidance under Japanese GAAP calls for net sales of JPY 121.8 billion, down 3.5%, with operating profit falling 43.9% to JPY 2 billion.
The company forecasts profit attributable to owners of parent of JPY 1.5 billion, down 56.5%, with full-year EPS of JPY 26.11.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kyorin Pharmaceutical Co. Ltd. published the original content used to generate this news brief on July 30, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Kyorin Pharmaceutical Q1 FY27 profit attributable to owners drops 60.8% to JPY 824 million

You may also like

Crypto prices